How the discovery of neuronal stem cells have changed neuroscience and perspective for the therapy for central nervous system illnesses

Mostly-incurable central nervous system diseases and disorders, such as neurodegenerative diseases, stroke, brain and spinal cord injuries and psychiatric illnesses, represent one of the most difficult health problems today, in terms of mortality, disability, productivity loss and health-care costs. After disappointing results regarding the translational value of neuroprotective molecules and protocols from preclinical research on animals to clinic, a new hope for the developing effective treatments for brain and spinal cord disorders came with the discovery of neuronal stem and progenitor cells, which have the potential to differentiate into a myriad of different glial and neuronal cell types. The basic biology behind the neuronal stem cells is becoming discovered, paving the way to possibilities for their manipulation and reprograming and for their clinical applications. Some of those protocols and clinical trials are described in this paper, with the emphasis on spinal cord injury treatments

Circular RNAs: The Novel Actors in Pathophysiology of Spinal Cord Injury

Spinal Cord Injury (SCI) can elicit a progressive loss of nerve cells promoting disability, morbidity, and even mortality. Despite different triggering mechanisms, a cascade of molecular events involving complex gene alterations and activation of the neuroimmune system influence either cell damage or repair. Effective therapies to avoid secondary mechanisms underlying SCI are still lacking. The recent progression in circular RNAs (circRNAs) research has drawn increasing attention and opened a new insight on SCI pathology. circRNAs differ from traditional linear RNAs and have emerged as the active elements to regulate gene expression as well as to facilitate the immune response involved in pathophysiology-related conditions. In this review, we focus on the impact and possible close relationship of circRNAs with pathophysiological mechanisms following SCI, where circRNAs could be the key transcriptional regulatory molecules to define neuronal death or survival. Advances in circRNAs research provide new insight on potential biomarkers and effective therapeutic targets for SCI patients.Fil: Sámano, Cynthia. Universidad Autónoma Metropolitana; MéxicoFil: Mladinic, Miranda. University Of Rijeka; CroaciaFil: Mazzone, Graciela Luján. Universidad Austral. Facultad de Ciencias Biomédicas. Instituto de Investigaciones en Medicina Traslacional. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones en Medicina Traslacional; Argentin

Molecular Mechanisms Underlying Cell Death in Spinal Networks in Relation to Locomotor Activity After Acute Injury in vitro

Understanding the pathophysiological changes triggered by an acute spinal cord injury is a primary goal to prevent and treat chronic disability with a mechanism-based approach. After the primary phase of rapid cell death at the injury site, secondary damage occurs via autodestruction of unscathed tissue through complex cell-death mechanisms that comprise caspase-dependent and caspase-independent pathways. To devise novel neuroprotective strategies to restore locomotion, it is, therefore, necessary to focus on the death mechanisms of neurons and glia within spinal locomotor networks. To this end, the availability of in vitro preparations of the rodent spinal cord capable of expressing locomotor-like oscillatory patterns recorded electrophysiologically from motoneuron pools offers the novel opportunity to correlate locomotor network function with molecular and histological changes long after an acute experimental lesion. Distinct forms of damage to the in vitro spinal cord, namely excitotoxic stimulation or severe metabolic perturbation (with oxidative stress, hypoxia/aglycemia), can be applied with differential outcome in terms of cell types and functional loss. In either case, cell death is a delayed phenomenon developing over several hours. Neurons are more vulnerable to excitotoxicity and more resistant to metabolic perturbation, while the opposite holds true for glia. Neurons mainly die because of hyperactivation of poly(ADP-ribose) polymerase-1 (PARP-1) with subsequent DNA damage and mitochondrial energy collapse. Conversely, glial cells die predominantly by apoptosis. It is likely that early neuroprotection against acute spinal injury may require tailor-made drugs targeted to specific cell-death processes of certain cell types within the locomotor circuitry. Furthermore, comparison of network size and function before and after graded injury provides an estimate of the minimal network membership to express the locomotor program

El trauma raquimedular

A medula espinhal dos mamíferos adultos não permite a regeneração de axônios. Por razões ainda desconhecidas, as fibras neurais falham em cruzar o sítio da lesão, como se não houvesse crescimento, desde a primeira tentativa. Quais mecanismos poderiam explicar a perda da capacidade de regeneração? As cicatrizes formadas pelas células da glia seriam uma consequência da falha na regeneração ou a causa? Diversas linhas de evidência sugerem que a regeneração da medula espinhal seria impedida no sistema nervoso central pela ação de fatores locais no sítio da lesão, e que o sistema nervoso central não-lesado é um meio permissivo para o crescimento axonal, na direção de alvos específicos. Uma vez que os axônios são induzidos adequadamente a cruzar a lesão com o auxílio de implantes, fármacos ou células indiferenciadas, as fibras em regeneração podem encontrar a via específica e estabelecer conexões corretas. O que ainda não se sabe é que combinação de moléculas induz/inibe o potencial de regeneração do tecido e que mecanismos permitem aos neurônios formarem conexões específicas com os alvos com os quais são programados a fazer.The adult mammal spinal cord does not allow axons regeneration. For unknown reasons, the neural fibers fail in coming across the site of the lesion, as if there were no growing from the first try. What mechanisms may explain the lost of regeneration capability? Are scars formed by glial cells a consequence of regeneration fail or the cause? Several evidence lines suggest that spinal cord regeneration would be blocked in the central nervous system by actions of local factors in the site of the wound, and no injured central nervous system is a permissive way for the axonal growing into specific targets. If axons are correctly induced to cross the injury, supported by implants, drugs and undifferentiated cells, the fibers in regeneration may find a specific way to establish the right connections. The combination of molecules which induce/inhibit the regeneration potential of the tissue remains unknown, as well as the mechanisms that enable the neuron to make specific connections with targets it is programmed to connect with.La medula espinal de los mamíferos adultos no permite la regeneración de los axones. Por razones aun no conocidas, las fibras neurales fallan en la tarea de cruzar por el sitio de la lesión, como si no hubiese crecimiento, desde el primer intento. ¿Cuáles mecanismos podrían explicar la pérdida de la capacidad de la regeneración? ¿Las cicatrices formadas por las células de la glía son una consecuencia del fallo en la regeneración o serían la causa? Diversas líneas de evidencia sugieren que la regeneración de la medula espinal sería impedida en el sistema nervioso central por la acción de factores locales en el sitio de la lesión, y que el sistema nervioso central no lesionado es un medio permisivo para el crecimiento axonal, en la dirección de dianas específicas. Una vez que los axones sean inducidos adecuadamente a cruzar la lesión, con auxilio de implantes, fármacos o células indiferenciadas, las fibras en regeneración podrían encontrar la vía específica y establecer conexiones correctas. Lo que aun es desconocido es que combinación de moléculas induce/inhibe el potencial de regeneración del tejido y cuáles mecanismos permiten a las neuronas formar conexiones específicas, con las dianas que son programadas a hacer.FAPESPCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CNP

How the discovery of neuronal stem cells have changed neuroscience and perspective for the therapy for central nervous system illnesses

Mostly-incurable central nervous system diseases and disorders, such as neurodegenerative diseases, stroke, brain and spinal cord injuries and psychiatric illnesses, represent one of the most difficult health problems today, in terms of mortality, disability, productivity loss and health-care costs. After disappointing results regarding the translational value of neuroprotective molecules and protocols from preclinical research on animals to clinic, a new hope for the developing effective treatments for brain and spinal cord disorders came with the discovery of neuronal stem and progenitor cells, which have the potential to differentiate into a myriad of different glial and neuronal cell types. The basic biology behind the neuronal stem cells is becoming discovered, paving the way to possibilities for their manipulation and reprograming and for their clinical applications. Some of those protocols and clinical trials are described in this paper, with the emphasis on spinal cord injury treatments

ATF3 is a novel nuclear marker for migrating ependymal stem cells in the rat spinal cord

The present study identified ATF3 as a novel dynamic marker for ependymal stem/progenitor cells (nestin, vimentin and SOX2 positive) around the central canal of the neonatal or adult rat spinal cord. While quiescent ependymal cells showed cytoplasmic ATF3 expression, during 6-24. h in vitro these cells mobilized and acquired intense nuclear ATF3 staining. Their migratory pattern followed a centrifugal pathway toward the dorsal and ventral funiculi, reminiscent of the rostral migratory stream of the brain subventricular stem cells. Thus, the chain cell formation was, by analogy, termed funicular migratory stream (FMS). The FMS process preceded the strong proliferation of ependymal cells occurring only after 24. h in vitro. Pharmacological inhibition of MAPK-p38 and JNK/c-Jun (upstream effectors of ATF3 activation) prevented the FMS mobilization of ATF3 nuclear-positive cells. Excitotoxicity or ischemia-like conditions, reported to evoke neuronal and glial injury, did not further enhance migration of ependymal cells at 24. h, suggesting that, at this early stage of damage, the FMS phenomenon had peaked and that more extensive repair processes are delayed beyond this time point. ATF3 is, therefore, useful to identify activation and migration of endogenous stem cells of the rat spinal cord in vitro. \ua9 2014

Spinal cord neural stem cells heterogeneity in postnatal development

Neural stem cells are capable of generating new neurons during development as well as in the adulthood and represent one of the most promising tools to replace lost or damaged neurons after injury or neurodegenerative disease. Unlike the brain, neurogenesis in the adult spinal cord is poorly explored and the comprehensive characterization of the cells that constitute stem cell neurogenic niche is still missing. Moreover, the terminology used to specify developmental and/or anatomical CNS regions, where neurogenesis in the spinal cord occurs, is not consensual and the analogy with the brain is often unclear. In this review, we will try to describe the heterogeneity of the stem cell types in the spinal cord ependymal zone, based on their origin and stem cell potential. We will also consider specific animal in vitro models that could be useful to identify “the right” stem cell candidate for cell replacement therapies

Monodelphis domestica: a new source of mammalian primary neurons in vitro

Mammalian central nervous system (CNS) in vitro cell models are mostly derived from the late embryonic or early postnatal mice and rats. Other mammalian species have been less used, meaning that inter-species diversity is not sufficiently investigated and that the additional comparative analyses are required to avoid misinterpretations in translating the knowledge to humans. We have recently established and extensively characterized the long-term primary dissociated cortical neuronal cultures derived from the neonatal grey South American short-tailed opossums [Monodelphis (M.) domestica] that we propose as a new source of mammalian CNS cells for in vitro developmental and regeneration studies. These cultures are unique for the possibility to obtain embryonic-like CNS cells from the postnatal animals, at wide range of postnatal days

Kainate and metabolic perturbation mimicking spinal injury differentially contribute to early damage of locomotor networks in the in vitro neonatal rat spinal cord

Acute spinal cord injury evolves rapidly to produce secondary damage even to initially spared areas. The result is loss of locomotion, rarely reversible in man. It is, therefore, important to understand the early pathophysiological processes which affect spinal locomotor networks. Regardless of their etiology, spinal lesions are believed to include combinatorial effects of excitotoxicity and severe stroke-like metabolic perturbations. To clarify the relative contribution by excitotoxicity and toxic metabolites to dysfunction of locomotor networks, spinal reflexes and intrinsic network rhythmicity, we used, as a model, the in vitro thoraco- lumbar spinal cord of the neonatal rat treated (1 h) with either kainate or a pathological medium (containing free radicals and hypoxic/aglycemic conditions), or their combination. After washout, electrophysiological responses were monitored for 24 h and cell damage analyzed histologically. Kainate suppressed fictive locomotion irreversibly, while it reversibly blocked neuronal excitability and intrinsic bursting induced by synaptic inhibition block. This result was associated with significant neuronal loss around the central canal. Combining kainate with the pathological medium evoked extensive, irreversible damage to the spinal cord. The pathological medium alone slowed down fictive locomotion and intrinsic bursting: these oscillatory patterns remained throughout without regaining their control properties. This phenomenon was associated with polysynaptic reflex depression and preferential damage to glial cells, while neurons were comparatively spared. Our model suggests distinct roles of excitotoxicity and metabolic dysfunction in the acute damage of locomotor networks, indicating that different strategies might be necessary to treat the various early components of acute spinal cord lesion

Proteomic analysis of opossum Monodelphis domestica spinal cord reveals the changes of proteins related to neurodegenerative diseases during developmental period when neuroregeneration stops being possible

One of the major challenges of modern neurobiology concerns the inability of the adult mammalian central nervous system (CNS) to regenerate and repair itself after injury. It is still unclear why the ability to regenerate CNS is lost during evolution and development and why it becomes very limited in adult mammals. A convenient model to study cellular and molecular basis of this loss is neonatal opossum (Monodelphis domestica). Opossums are marsupials that are born very immature with the unique possibility to successfully regenerate postnatal spinal cord after injury in the first two weeks of their life, after which this ability abbruptly stops. Using comparative proteomic approach we identified the proteins that are differentially distributed in opossum spinal tissue that can and cannot regenerate after injury, among which stand out the proteins related to neurodegenerative diseases (NDD), such as Huntington, Parkinson and Alzheimer's disease, previously detected by comparative transcriptomics on the analog tissue. The different distribution of the selected proteins detected by comparative proteomics was further confirmed by Western blot (WB), and the changes in the expression of related genes were analysed by quantitative reverse transcription PCR (qRT-PCR). Furthermore, we explored the cellular localization of the selected proteins using immunofluorescent microscopy. To our knowledge, this is the first report on proteins differentially present in developing, non-injured mammalian spinal cord tissue with different regenerative capacities. The results of this study indicate that the proteins known to have an important role in the pathophysiology of neurodegeneration in aged CNS, could also have an important phyisological role during CNS postnatal development and in neuroregeneration process